I take what Ranja said to me with a grain of salt,after all she was brought in as a deal maker and was demoted to IR,so she can`t be too happy. I was nice,considering how little she`s done for the company,because I wanted to tell her what I really thought of her and I did`nt. No excuse for the inept individuals brought in by Dan and I`ll bet Ranja will be gone soon enough. She said all options were on the table for Axal/Cervix,and I said even doing a different trial that would cost less,and she said yes. So IMO,whatever Ken decides now,is mainly a decision based on lack of cash to proceed solo,so if no partner soon it`ll lead to it being shelved,,maybe temporarily or maybe permanently.The company may be able to stall long enough for new data from the trial,and then possibly obtain a partnership,so that would be another option,and I believe if Ken gets a deal on Head and Neck and Anal before April 2019,he may be able to accomplish this goal. If not we`ll see another round of dilution, and with the reduced burn rate from the wind down of Axal/Cervix,it`ll be taken as a positive,going forward from there. Many things can transpire by way of positives by the middle of next year,so things are`nt as bad as some want to think just yet. I don`t like CVI getting in and it appears that they are shorting the stock in the high 80`s to high 90`s and are doing that to hold the stock and are hoping Ken comes up empty,and is forced to do another round of dilution,where CVI will get the shares needed to cover that short,,plus more warrants. It`s ugly,if that`s truly the case,but eventually they`ll try a pump and dump on top of any positive news going forward,after they`ve stolen whatever they can,and they`ll need to get the stock high enough to make good money on those warrants,and the stock will need to be real high to handle the volume of them selling...I`ll be waiting for that because that`s gotta be their end game..
News 
Market Data 
Discover 
